Mardi Dier, CFO & Executive Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 954 shares at $64.55 ($63K) on 2022-03-03, disclosed to the SEC on 2022-03-03.
Scheduled sale ($63k) by CFO & Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.62 | 534 | $36K | 56.8% |
| 2 | $64.55 | 420 | $27K | 43.2% |
| Total | $65.71 avg | 954 | $63K | 100% |
| Filing → |
| MDGL | SELL | 2025-12-03 | $3.6M | — | Filing → |
| MDGL | SELL | 2025-03-12 | $167K | — | Filing → |
| MDGL | SELL | 2025-03-05 | $1.3M | — | Filing → |